A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19Dave Singh,Maxim Bogus,Valentyn Moskalenko,Robert Lord,Edmund J Moran,Glenn D Crater,David L Bourdet,Nathan D Pfeifer,Jacky Woo,Elad Kaufman,David A Lombardi, Emily Y Weng,Tuan Nguyen,Ashley Woodcock,Brett Haumann,Rajeev SaggarEUROPEAN RESPIRATORY JOURNAL（2021）引用 31|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
